Behavior of the Dengue Virus in Solution

Journal of Medical Virology

Volumn 71, Issue 4, 2003, Pages 532-539

  Sithisarn, Patchima ^a   Suksanpaisan, Lukkana ^a   Thepparit, Chutima ^a   Smith, Duncan R ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Aggregation; Electron microscopy; Flavivirus; Infection; Serotype

Indexed keywords

CHELATING AGENT; MAGNESIUM ION; VIRUS RNA;

ARTICLE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ELECTRON MICROSCOPY; HALF LIFE TIME; NONHUMAN; PH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROOM TEMPERATURE; TEMPERATURE DEPENDENCE; VIRUS GENOME; VIRUS INFECTIVITY;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CULTURE MEDIA; DENGUE VIRUS; DNA, VIRAL; MICROSCOPY, ELECTRON; PLAQUE ASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SOLUTIONS; VERO CELLS; VIRULENCE;

DENGUE VIRUS; FLAVIVIRUS;

EID: 0142244382     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10520     Document Type: Article

References (29)

1. Allison SL, Schalich J, Stiasny K, Mandl CW, Kunz C, Heinz FX. 1995. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol 69:695-700.
2. Burke DS, Nisalak A, Johnson DE, Scott RM. 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38:172-180.
3. Chen RF, Yeh WT, Yang MY, Yang KD. 2001. A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunol Med Microbiol 30:1-7.
4. Guzman MG, Kourf G. 2002. Dengue: An update. Lancet Infect Dis 2:33-42.
5. Halstead SB. 1988. Pathogenesis of dengue: Challenges to molecular biology. Science 239:476-478.
6. Halstead SB. 1989. Antibody, macrophages, dengue virus infection, shock and hemorrhage: A pathogenetic cascade. Rev Infect Dis 11:S830-S839.
7. Halstead SB, O'Rourke EJ. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146:201-217.
8. Halstead SB, Nimmannitya S, Yamarat C, Russel PK. 1967. Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol 20:96-103.
9. Halstead SB, Nimmannitya S, Cohen SN. 1970. Observations related to disease pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 42:311-328.
10. Henchal EA, Putnak JR. 1990. The dengue viruses. Clin Microbiol Rev 3:376-396.
11. Hung SL, Lee PL, Chen HW, Chen LK, Kao CL, King CC. 1999. Analysis of the steps involved in dengue virus entry into host cells. Virology 257:156-167.
12. Khumthong R, Angsuthanasombat C, Panyim S, Katzenmeier G. 2002. In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates. J Biochem Mol Biol 35:206-212.
13. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhage fever. Am J Trop Med Hyg 40:444-451.
14. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. 2002. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185:1213-1221.
15. Littaua R, Kurane I, Ennis FA. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144:3183-3186.
16. Morens DM. 1994. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 19:500-512.
17. Morens DM, Sather GE, Gubler DJ, Rammohan M, Woodall JP. 1987. Dengue shock syndrome in an American traveler with primary dengue 3 infection. Am J Trop Med Hyg 36:424-426.
18. Pettersson RF. 1991. Protein localization and virus assembly at intracellular membranes. Curr Top Microbiol Immunol 170:67-106.
19. Pinheiro FP, Corber SJ. 1987. Global situation of dengue and dengue hemorrhagic fever, and its emergence in the Americas. World Health Stat Q 50:161-169.
20. Russell PK, Yuill TM, Nisalak A, Udomsakdi S, Gould D, Winter PE. 1968. An insular outbreak of dengue hemorrhagic fever. II Virologic and serologic studies. Am J Trop Med Hyg 17:600-608.
21. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, Phanthumachinda B, Halstead SB. 1984. Risk factors in dengue shock syndrome: A prospective epidemiologic study in Rayong, Thailand. I: The 1980 outbreak. Am J Epidemiol 120:653-669.
22. Scott RM, Nimmannitya S, Bancroft WH, Mansuwan P. 1976. Shock syndrome in primary dengue infections. Am J Trop Med Hyg 25: 866-874.
23. Sierra B, Garcia G, Perez AB, Morier L, Rodriguez R, Alvarez M, Guzman MG. 2002. Long-term memory cellular immune response to dengue virus after a natural primary infection. Int J Infect Dis 6:125-128.
24. Stiasny K, Allison SL, Mandl CW, Heinz FX. 2001. Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J Virol 75:7392-7398.
25. Stiasny K, Allison SL, Schalich J, Heinz FX. 2002. Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J Virol 76:3784-3790.
26. Sudiro TM, Zivny J, Ishiko H, Green S, Vaughn DW, Kalayanarooj S, Nisalak A, Norman JE, Ennis FA, Rothman AL. 2001. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol 63:29-34.
27. Suksanpaisan L, Smith DR. 2003. Analysis of saturation binding and saturation infection for dengue serotypes 1 and 2 in liver cells. Intervirology 46:50-55.
28. Wang WK, Lee CN, Kao CL, Lin YL, King CC. 2000. Quantitative competitive reverse transcription-PCR for quantification of dengue virus RNA. J Clin Microbiol 38:3306-3310.
29. Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH, King CC. 2003. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: Implications for pathogenesis. Virology 305:330-338.